ABHD17AP4: A Potential Drug Target and Biomarker (G729495)

Target Name: ABHD17AP4

NCBI ID: G729495

ABHD17AP4

Other Name(s): FAM108A5P | ABHD17A pseudogene 4 | FAM108A5 | Abhydrolase domain containing 17A pseudogene P4

ABHD17AP4: A Potential Drug Target and Biomarker

Introduction

ABHD17AP4 is a gene that encodes a protein known as FAM108A5P. The protein is a member of the ABH domain family, which is a family of proteins that are involved in various cellular processes, including cell adhesion, migration, and invasion. ABHD17AP4 is unique because it has been shown to be highly expressed in human tissues and has been implicated in the development and progression of various diseases, including cancer.

The search for new drug targets and biomarkers is an ongoing process in the pharmaceutical industry. Drug targets are proteins that are involved in the development and progression of diseases and are targeted by drugs to inhibit their activity. Biomarkers are proteins that are derived from cells or tissues and can be used to diagnose, monitor, or predict the progression of a disease.

ABHD17AP4 is a potential drug target because it has been shown to be involved in the development and progression of various diseases, including cancer. It is also a good candidate for biomarker because it is highly expressed in human tissues and has been shown to be involved in the development and progression of diseases.

The Protein encoded by ABHD17AP4

ABHD17AP4 is a member of the ABH domain family, which is a family of proteins that are involved in various cellular processes, including cell adhesion, migration, and invasion. The ABH domain is characterized by the presence of a unique calbindin-like repeat ( CLRS) in the cytoplasm of the cell. The CLRS is a characteristic of the ABH domain proteins that allows them to interact with various signaling molecules, including Wnt, FGF, and PDGF.

The ABHD17AP4 protein is 174 amino acids long and has a molecular weight of 21 kDa. It has a unique structure that is characterized by the presence of a N-terminal alpha-helix, a unique G-cellular bar

Protein Name: ABHD17A Pseudogene 4

The "ABHD17AP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ABHD17AP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets